Product Information
METRONIDAZOLE 250 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.1068 per EA under NDC 50111033306. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Nov 6, 1984. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
50111033306
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
METRONIDAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA070027FDA Approved
11/6/1984
TE Code
AB
On Market Since
9/30/1990
Pharmacological Classes
Price Statistics
The NADAC for METRONIDAZOLE 250 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 61.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1068 per EA |
|---|---|
| All-time high | $0.2872 (Mar 12, 2014) |
| All-time low | $0.0623 (Dec 17, 2025) |
| 52-week high | $0.1070 |
| 52-week low | $0.0623 |
| Median price | $0.1493 |
| Average price | $0.1711 |
| Largest weekly change | +36.9% (May 22, 2019) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 9% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METRONIDAZOLE 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METRONIDAZOLE 250 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.1068 per EA (NDC 50111033306), effective Aug 19, 2026.
How has the price of METRONIDAZOLE 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for METRONIDAZOLE 250 MG TABLET has declined 61.5%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for METRONIDAZOLE 250 MG TABLET?
Since Nov 28, 2013, the NADAC for METRONIDAZOLE 250 MG TABLET has ranged from a low of $0.0623 (Dec 17, 2025) to a high of $0.2872 (Mar 12, 2014), with a median of $0.1493 per EA.
Are there cheaper alternatives to METRONIDAZOLE 250 MG TABLET?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METRONIDAZOLE 250 MG TABLET, is $0.0970 per EA — about 9% below METRONIDAZOLE 250 MG TABLET.
Who manufactures METRONIDAZOLE 250 MG TABLET?
METRONIDAZOLE 250 MG TABLET (NDC 50111033306) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.